EDIE.NET

As treatment options continue to expand across numerous disease settings, new practice guidelines were released by the Society for Immunotherapy...

Data from the randomized, double-blind, placebo-controlled phase 3 NORA trial (NCT03705156) indicated that niraparib (Zejula) maintenance...

(UroToday.com) The field of advanced prostate cancer has rapidly progressed over the past 15 years. Prior to the publication of TAX-327, there...

Background Lutetium-177 [ 177Lu]Lu-PSMA-617 is a radiolabelled small molecule that delivers β radiation to cells expressing prostate-specific...

Lung cancer is more likely in people with idiopathic pulmonary fibrosis (IPF) than the public at large, and these patients should be given...

A recent study out of the United Kingdom finds patients with relapsed malignant mesothelioma can be treated effectively with single-agent...

People with idiopathic pulmonary fibrosis (IPF) in poorer health are less likely than healthier patients to tolerate more than one year of...

Patient-reported outcomes from the phase III CROWN study showed that time to treatment deterioration (TTD) in pain in chest, dyspnea, and cough...

Although survivors and patients with lung cancer felt that they were involved in the treatment decision-making process, nearly half of them...

Investigators noted comparable use of bevacizumab biosimilar and reference products among patients treated for metastatic colorectal cancer.A...